Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Avidity Biosciences, Inc. (RNA)  
$70.56 0.09 (0.13%) as of 4:30 Fri 11/21


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 141,750,000
Market Cap: 10.00(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $24.08 - $70.89
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avidity Biosciences is a biopharmaceutical company developing a new class of RNA therapies called Antibody Oligonucleotide Conjugates (AOCs) designed to combine the specificity of monoclonal antibodies, or mAbs, with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. Co.'s lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare monogenic muscle disease. Co. pipeline also includes AOC 1044, the lead of three programs for the treatment of Duchenne Muscular Dystrophy, and AOC 1020, designed to treat facioscapulohumeral muscular dystrophy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 178,772 667,262 932,817 2,524,815
Total Sell Value $8,490,298 $30,048,830 $38,455,222 $95,299,816
Total People Sold 7 10 10 11
Total Sell Transactions 12 25 49 96
End Date 2025-08-24 2025-05-23 2024-11-22 2023-11-23

   
Records found: 246
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hughes Steven George Chief Medical Officer   •       –      –    2025-10-22 4 AS $47.54 $105,015 D/D (2,209) 38,867 51%     
   Hughes Steven George Chief Medical Officer   •       –      –    2025-10-22 4 OE $10.16 $22,443 D/D 2,209 41,076     -
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2025-10-15 4 AS $50.15 $1,003,058 D/D (20,000) 97,130 40%     
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2025-10-15 4 OE $22.34 $446,800 D/D 20,000 117,130     -
   Mosbrooker Eric Chief Commercial Officer   •       –      –    2025-10-03 4 AS $45.38 $297,771 D/D (6,562) 55,000 50%     
   Mosbrooker Eric Chief Commercial Officer   •       –      –    2025-10-03 4 OE $9.05 $59,386 D/D 6,562 61,562     -
   Hughes Steven George Chief Medical Officer   •       –      –    2025-09-22 4 AS $40.58 $89,601 D/D (2,208) 38,867 67%     
   Hughes Steven George Chief Medical Officer   •       –      –    2025-09-22 4 OE $10.16 $22,433 D/D 2,208 41,075     -
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2025-09-15 4 AS $41.41 $621,143 D/D (15,000) 97,130 75%     
   Mccarthy Teresa Chief Human Resources Officer   •       –      –    2025-09-15 4 OE $22.34 $335,100 D/D 15,000 112,130     -
   Hughes Steven George Chief Medical Officer   •       –      –    2025-09-15 4 AS $45.41 $70,022 D/D (1,542) 38,867 75%     
   Hughes Steven George Chief Medical Officer   •       –      –    2025-09-15 4 OE $6.57 $10,131 D/D 1,542 40,409     -
   Flanagan W. Michael Chief Scientific Officer   •       –      –    2025-09-11 4 AS $38.94 $778,702 D/D (20,000) 80,195 72%     
   Flanagan W. Michael Chief Scientific Officer   •       –      –    2025-09-11 4 OE $14.22 $284,400 D/D 20,000 100,195     -
   Wilson Troy Edward Director   –       •      –    2025-09-05 4 AS $50.00 $1,475,000 D/D (29,500) 54,425 40%     
   Wilson Troy Edward Director   –       •      –    2025-09-05 4 OE $12.48 $180,960 D/D 14,500 83,925     -
   Boyce Sarah President and CEO   •       •      –    2025-09-05 4 AS $49.95 $2,497,435 D/D (50,000) 305,871 40%     
   Boyce Sarah President and CEO   •       •      –    2025-09-05 4 OE $1.24 $62,000 D/D 50,000 355,871     -
   Mosbrooker Eric Chief Commercial Officer   •       –      –    2025-09-03 4 AS $47.07 $308,936 D/D (6,563) 55,000 48%     
   Mosbrooker Eric Chief Commercial Officer   •       –      –    2025-09-03 4 OE $9.05 $59,395 D/D 6,563 61,563     -
   Gallagher Kathleen P. Chief Program Officer   •       –      –    2025-09-02 4 AS $47.42 $8,915 D/D (188) 50,204 49%     
   Boyce Sarah President and CEO   •       •      –    2025-08-28 4 AS $49.39 $1,234,700 D/D (25,000) 305,871 45%     
   Boyce Sarah President and CEO   •       •      –    2025-08-28 4 OE $1.24 $31,000 D/D 25,000 330,871     -
   Hughes Steven George Chief Medical Officer   •       –      –    2025-08-22 4 AS $46.40 $102,462 D/D (2,208) 38,867 52%     
   Hughes Steven George Chief Medical Officer   •       –      –    2025-08-22 4 OE $10.16 $22,433 D/D 2,208 41,075     -
  246 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us